Skip to main content
. 2017 Feb;29(1):57–65. doi: 10.21147/j.issn.1000-9604.2017.01.07

2.

The PFS and OS of patients with one extranodal involvement site (N=157)

Extranodal involvement site n 3-year PFS (%) 3-year OS (%)
PFS, progression-free survival; OS, overall survival; GI, gastrointestinal.
Waldeyer’s ring 43 81.1±6.0 88.0±5.0
Thyroid 9 77.8±13.9 88.9±10.5
Salivary gland 4 75.0±21.7 100
GI tract 49 68.9±6.7 74.6±6.4
Liver 3 66.7±27.2 66.7±27.2
Pancreas 3 66.7±27.2 66.7±27.2
Bone 11 54.5±15.0 72.7±13.4
Breast 9 55.6±16.6 66.7±15.7
Female genital tract 5 60.0±21.9 60.0±21.9
Thorax 6 50.0±20.4 50.0±20.4
Paranasal sinuses 6 50.0±20.4 50.0±20.4
Bone marrow 6 41.7±22.2 50.0±20.4
Brain 3 0 0